Stay updated on AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC
Sign up to get notified when there's something new on the AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC page.

Latest updates to the AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check14 days agoChange DetectedA notice about NIH’s website transition and use of “Super Intelligence” in place of “Artificial Intelligence” appears above the study record.SummaryDifference0.6%

- Check21 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2. The study record content remains unchanged.SummaryDifference0.1%

- Check28 days agoChange DetectedA new study-record version was submitted on October 8, 2026, updating the study status and contact/location information.SummaryDifference0.5%

- Check49 days agoChange DetectedThe record history page now displays the latest revision as v3.7.0, replacing the previous v3.6.6. This indicates a platform update rather than changes to the study data.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry (v3.6.6) was added to the study history, and the previous revision (v3.6.5) was removed. This reflects an update to the record’s versioning rather than any change to study data or content.SummaryDifference0.1%

Stay in the know with updates to AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC
Enter your email address, and we'll notify you when there's something new on the AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC page.